Inventor · disambiguated record
Curtis L. Ruegg
Also filed as: RUEGG CURTIS · RUEGG CURTIS L · RUEGG CURTIS LANDON
18 granted patents·20 pending applications·564 citations·filing 1995–2025
95Inventor score
Top patents by PatentIndex Score
38 records- 0197US9469849B2Methods and systems for purifying non-complexed botulinum neurotoxinREVANCE THERAPEUTICS INC·Filed 2015·Granted Oct 18, 2016·23 cites·67 claims
- 0296US6080409AImmunostimulatory methodDENDREON CORP·Filed 1995·Granted Jun 27, 2000·152 cites·7 claims
- 0395US10201594B2Compositions and methods for safe treatment of rhinitisREVANCE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·14 cites·8 claims
- 0495US10111939B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·16 cites·38 claims
- 0592US9340587B2Albumin-free botulinum toxin formulationsTHOMPSON STEWART A·Filed 2010·Granted May 17, 2016·22 cites·146 claims
- 0691US6812023B1Methods of producing membrane vesiclesANOSYS INC·Filed 2000·Granted Nov 2, 2004·181 cites·9 claims
- 0789US7414108B2Composition and method for producing an immune response against tumor-related antigensDENDREON CORP·Filed 2004·Granted Aug 19, 2008·29 cites·6 claims
- 0888US2024382571A1Albumin-Free Botulinum Toxin FormulationsREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0987US9956435B2Injectable botulinum toxin formulationsRUEGG CURTIS L·Filed 2009·Granted May 1, 2018·15 cites·49 claims
- 1087US6210662B1Immunostimulatory compositionDENDREON CORP·Filed 1999·Granted Apr 3, 2001·47 cites·3 claims
- 1186US5976546AImmunostimulatory compositionsDENDREON CORP·Filed 1998·Granted Nov 2, 1999·58 cites·2 claims
- 1285US11351232B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Granted Jun 7, 2022·1 cites·19 claims
- 1383US2024058628A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1477US11911449B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 1577US11466262B2Methods and systems for purifying non-complexed botulinum neurotoxinREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 11, 2022·0 cites·23 claims
- 1676US12257293B2Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2021·Granted Mar 25, 2025·0 cites·9 claims
- 1772US2025319168A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1871US2025332232A1Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disordersREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1967US11471708B2Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·13 claims
- 2067US2021189326A1Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositionsREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2166US2022062400A1Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2264US2020345819A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2364US2017029795A1Methods and Systems for Purifying Non-Complexed Botulinum NeurotoxinREVANCE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2464US2014120077A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2563US2020179498A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2658US2018214717A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2754US12161703B2Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disordersREVANCE THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·0 cites·31 claims
- 2854US2011092682A1Methods and Systems for Purifying Non-Complexed Botulinum NeurotoxinREVANCE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2953US2014154237A1Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositionsWAUGH JACOB·Filed 2011·Application pending·0 cites
- 3052US2011106021A1Device and Method for Topical Application of Therapeutics or Cosmetic CompositionsREVANCE THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3152US2012294844A1Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin CompositionsWAUGH JACOB M·Filed 2011·Application pending·0 cites
- 3251US2012196349A1Methods and Systems for Purifying Non-Complexed Botulinum NeurotoxinRUEGG CURTIS L·Filed 2010·Application pending·0 cites
- 3347US5998599AGrowth arrest gene compositions and methodsDENDREON CORP·Filed 1997·Granted Dec 7, 1999·4 cites·8 claims
- 3446US2018311333A1Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3545US2012238969A1Device and Method for Topical Application of Therapeutics or Cosmetic CompositionsRUEGG CURTIS L·Filed 2010·Application pending·0 cites
- 3642US2006147520A1Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulationRUEGG CURTIS·Filed 2005·Application pending·0 cites
- 3733US2004241176A1Method of producing membrane vesiclesAP CELLS INC·Filed 2001·Application pending·0 cites
- 3826US5646251AAlloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamilyTRUSTEES OF LEELAND STANFORD J·Filed 1995·Granted Jul 8, 1997·2 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Curtis L. Ruegg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →